Jennifer Rohn

Education Rohn graduated from Oberlin College with a Bachelor of Arts degree in Biology in 1990. Following this Rohn was awarded a Doctor of Philosophy degree in 1996 from the University of Washington for work on Feline leukemia virus (FeLV).

Career and research After postdoctoral research at the Cancer Research UK London Research Institute (now incorporated into the Francis Crick Institute) studying apoptosis and cancer with Gerard Evan, Rohn moved to the Netherlands to lead a research group at the biotech start-up company, Leadd BV. After moving into scientific publishing for a few years, Rohn joined University College London in 2007, setting up her own group in the Centre for Nephrology at University College London in 2015.

Rohn's initial research interest was in virology. Over the following 15 years Rohn studied apoptosis and the shape of cells. Rohn's current research interests include study of urinary tract infections. Rohn works with engineers to put antibiotics within core-shell capsules to treat persistent urinary tract infections. Rohn grows bladder epithelia in culture to test new treatments for urinary tract infections.

Publications Rohn's first novel, Experimental Heart, was published by Cold Spring Harbor Laboratory Press (CSHLP) in 2008. This is written in the lab lit genre, which she is well known for championing, was also published by CSHLP in November 2010. Her third novel, Cat Zero, was published by Bitingduck Press in June 2018. Rohn has also had short fiction, news and opinion published in Nature and The Guardian

Awards and honours In 2011, Rohn won the inaugural Research Fortnight "Achiever of the Year" award, and received the Society for Experimental Biology's President's Medal in the Education and Public Affairs Section. She won the Suffrage Science award in 2013.